(Q24245347)

2 July 2019

meta-analysis

0 references

review article

1 reference

title

Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria (English)

1 reference

2 July 2019

0 references

0 references

1 reference

H Bukirwa

1

H

Bukirwa

1 reference

2 July 2019

L Orton

series ordinal

2

author given names

L

author last names

Orton

1 reference

2 July 2019

publication date

19 October 2005

1 reference

2 July 2019

Cochrane Database of Systematic Reviews

published in

1 reference

2 July 2019

issue

4

1 reference

2 July 2019

page(s)

CD004531

1 reference

2 July 2019

Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Efficacies of mefloquine alone and of artesunate followed by mefloquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Neurotoxicity in animals due to arteether and artemether.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of 'dormancy', a partial cytostatic effect of the drug, and its implication for treatment regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Chemotherapy and prevention of drug-resistant malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Artemisinin derivatives for treating uncomplicated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Artemisinin derivatives for treating severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Malaria, the submerged disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Effects of artemisinin derivatives on malaria transmissibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Treatment of falciparum malaria in Vietnamese children: the need for combination therapy and optimized dosage regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Can amodiaquine be resurrected?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Averting a malaria disaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Epidemiology of drug-resistant malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

Randomized trial of artesunate and mefloquine in comparison with quinine sulfate to treat P. falciparum malaria pregnant women

21 January 2018

1 reference

12 December 2020

Lack of prediction of mefloquine and mefloquine-artesunate treatment outcome by mutations in the Plasmodium falciparum multidrug resistance 1 (pfmdr1) gene for P. falciparum malaria in Peru

1 reference

12 December 2020

Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru

1 reference

12 December 2020

Drug resistant malaria, with special reference to Thailand

1 reference

12 December 2020

Neuropsychiatric side effects after the use of mefloquine

1 reference

12 December 2020

Randomized trial of mefloquine alone and artesunate followed by mefloquine for the treatment of acute uncomplicated falciparum malaria

1 reference

12 December 2020

Pharmacokinetics of mefloquine alone or in combination with artesunate.

1 reference

12 December 2020

An efficacy and tolerance study of oral artesunate alone and in combination with mefloquine in the treatment of uncomplicated falciparum malaria in an endemic area of Pará, Brazil

1 reference

12 December 2020

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo

2 references

12 December 2020

https://api.crossref.org/works/10.1002%2F14651858.CD004531.PUB2

7 January 2021

inferred from DOI database lookup

A comparative study of artesunate and artemether in combination with mefloquine on multidrug resistant falciparum malaria in eastern Thailand

1 reference

12 December 2020

Research on new antimalarial drugs and the use of drugs in combination at the Bangkok Hospital for Tropical Diseases

1 reference

12 December 2020

10.1002/14651858.CD004531.PUB2

Identifiers

DOI

1 reference

2 July 2019

release_h7zxzkeh55cbdb2ktuhzdxxhea

Fatcat ID

0 references

PMCID

6532646

1 reference

2 July 2019

PubMed ID

16235367

1 reference

2 July 2019